Delivery Order SPE2DB20D2014-SPE2DB25FC68P
- Not listed
- The Defense Logistics Agency awarded a $2,646.95 delivery order to AmerisourceBergen Drug Corp for Januvia 25 mg tablets (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs, likely for...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Januvia 25 mg tablets (90-count) under a firm fixed-price contract valued at $2,977.41. This delivery order represents a child contract action issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The award...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $6,429.02. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,954.85 to AmerisourceBergen Drug Corp for supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract type. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,728.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,101.75 for Januvia 50 mg tablets (90-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC68PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,251.96 to AmerisourceBergen Drug Corp for the supply of Januvia 25 mg tablets (90-count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare systems under the Defense Logistics Agency's medical supply chain operations. This award is issued as a child delivery order under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor for pharmaceutical and medical supplies, AmerisourceBergen Drug Corp fulfills a critical role in supporting the Defense Health Agency and other federal healthcare systems with brand-name and generic medications across multiple therapeutic domains. The non-set-aside status reflects the company's competitive capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.3k | 8/7/25 |